Therapeutic properties of rice constituents and derivatives (Oryza sativa L.): A review update.
Saved in:
| Title: | Therapeutic properties of rice constituents and derivatives (Oryza sativa L.): A review update. |
|---|---|
| Authors: | Burlando, Bruno1 burlando@unipmn.it, Cornara, Laura2 |
| Source: | Trends in Food Science & Technology. Nov2014, Vol. 40 Issue 1, p82-98. 17p. |
| Subjects: | Rice, Inflammation treatment, Rice farming, Traditional medicine, Hypercholesteremia treatment, Skin disease treatment, Brown rice, Therapeutics |
| Abstract: | Rice is used in traditional medicines as a remedy against inflammation, gastrointestinal ailments, hypercholesterolemia, diabetes, and skin diseases. Experimental and clinical evidence indicate that brown rice and bran oil reduce hypercholesterolemia and cardiovascular risk, rice bran is anti-inflammatory and immunostimulatory, the monacolin-rich red yeast rice regulates hypercholesterolemia, and the GABA-rich germinated brown rice has chemopreventive effects. The rice constituent γ-oryzanol has been intensively investigated for cholesterol regulation and antioxidant/anti-inflammatory activities. Bran derivatives and other products are used for dermatologic and cosmetic applications. Pharmacologically relevant compounds could be extracted from rice byproducts, providing an economic boost to rice farming and processing. [ABSTRACT FROM AUTHOR] |
| Copyright of Trends in Food Science & Technology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
Be the first to leave a comment!
